Pharmaceutical combination for the treatment of LUTS comprising a PDE5 inhibitor and a muscarinic antagonist

Details for Australian Patent Application No. 2006327882 (hide)

Owner Pfizer Products Inc.

Inventors Suesserman, Michael Allen; Mastrell, Carl Erik Johan

Agent Spruson & Ferguson

Pub. Number AU-A-2006327882

PCT Pub. Number WO2007/072169

Priority 60/757,720 09.01.06 US; 60/752,625 20.12.05 US

Filing date 19 December 2006

Wipo publication date 28 June 2007

International Classifications

A61P 13/00 (2006.01) Drugs for disorders of the urinary system

A61K 31/025 (2006.01)

A61K 31/137 (2006.01) - Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine

A61K 31/221 (2006.01)

A61K 31/519 (2006.01) - ortho- or peri-condensed with heterocyclic rings

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

Event Publications

19 June 2008 PCT application entered the National Phase

  PCT publication WO2007/072169 Priority application(s): WO2007/072169

31 March 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006327883-Remotely controlled electronically actuated vehicle differential

2006327877-Estrogen modulators